Nima has been awarded another Small Business Innovation Research grant from the National Institutes of Health to aid in peanut sensor development for consumers. The phase 1 funding amount released is more than $290,000, which will help fund our research and development of a Nima sensor for peanut, which is anticipated for release in 2017.
The objective of this project is to develop and commercialize an economical, accurate, fast and portable device for peanut detection in foods, which can be readily used by consumers on a regular basis. It will provide peanut-sensitive consumers, parents of children with food sensitivities, health care providers, food manufacturers and restaurants with a means of testing foods to better verify food ingredients, thereby improving consumer health and quality of life.
The SBIR program is one of the largest sources of early-stage capital for innovative small companies in the United States. It allows U.S.-owned and operated small businesses to engage in federal research and development that has a strong potential for commercialization. A key objective of this work is “translating promising technologies to the private sector through strategic public and private partnerships, so that life-saving innovations reach consumer markets.”
The NIH SBIR program funds early stage small businesses that are seeking to commercialize innovative biomedical technologies. This competitive program helps small businesses participate in federal research and development, develop life-saving technologies and create jobs.
This is the second SBIR grant from NIH given to Nima in the past year. In 2015, NIH awarded Nima a fast track SBIR grant for the development of its gluten sensor. While Nima for gluten is still top priority this year, we are furiously working to expand our game-changing technology to even more people who need it.